Overview

Safety Study of Preoperative Sunitinib and Radiation in Soft Tissue Sarcoma

Status:
Completed
Trial end date:
2015-02-01
Target enrollment:
Participant gender:
Summary
To evaluate the toxicity of sunitinib concurrently given with irradiation for preoperative treatment of locally advanced or recurrent soft tissue sarcoma.
Phase:
Phase 1
Details
Lead Sponsor:
Heidelberg University
Collaborator:
German Research Foundation
Treatments:
Sunitinib